Copyright
©The Author(s) 2021.
World J Gastroenterol. Nov 7, 2021; 27(41): 7173-7189
Published online Nov 7, 2021. doi: 10.3748/wjg.v27.i41.7173
Published online Nov 7, 2021. doi: 10.3748/wjg.v27.i41.7173
Figure 1 Study workflow.
A: Segmentation of the region of interest; B: Extraction and selection of radiomics features; C: Construction of nomogram; D: Comparison of model performance; E: Decision curve analysis and overall survival comparisons between the training and validation sets. ROI: Region of interest; cHCC-CCA: Combined hepatocellular carcinoma and cholangiocarcinoma; LASSO: Least absolute shrinkage and selection operator; OS: Overall survival; ROC: Receiver operating characteristic.
- Citation: Tang YY, Zhao YN, Zhang T, Chen ZY, Ma XL. Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma. World J Gastroenterol 2021; 27(41): 7173-7189
- URL: https://www.wjgnet.com/1007-9327/full/v27/i41/7173.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i41.7173